Eberbach, Germany

Stefan Ritsert


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 60(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Stefan Ritsert

Introduction

Stefan Ritsert is a notable inventor based in Eberbach, Germany. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on solid pharmaceutical dosage forms. His expertise and dedication to research have led to the development of a unique formulation that enhances drug delivery.

Latest Patents

Stefan Ritsert holds a patent for "Memantine-containing solid pharmaceutical dosage forms having an extended two-phase release profile." This invention provides solid pharmaceutical compositions that contain memantine, characterized by the presence of both water-soluble and water-insoluble salts of casein. The formulation is designed to achieve an extended release profile, making it a valuable advancement in pharmaceutical technology. The patent details a process for producing these compositions, which consist of a total amount of casein salts between 5 and 98% by weight.

Career Highlights

Stefan Ritsert is associated with Merz+Co. GmbH & Co., where he has contributed to various research initiatives. His work has focused on improving pharmaceutical formulations, which has had a positive impact on patient care and treatment outcomes. With a patent portfolio that includes one significant patent, Ritsert continues to be an influential figure in the pharmaceutical industry.

Collaborations

Stefan has collaborated with esteemed colleagues such as Eberhard Nurnberg and Erhard Seiller. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Stefan Ritsert's contributions to pharmaceutical innovations exemplify the importance of research and development in improving drug formulations. His work not only enhances the efficacy of medications but also demonstrates the potential for advancements in patient treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…